wordpress-seo
domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init
action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/intelligentwr/nursingassignmentcrackers/wp-includes/functions.php on line 6114Marcus, an 18-year-old high school senior, presents with symptoms of difficulty sleeping and feeling sad, which result in an initial diagnosis of depression. His mother later reports, however, that Marcus exhibits symptoms of irritability and risk-taking behaviors. (His little brother reported to his mother that they were driving over 90 miles an hour on the highway.) After further evaluation, Marcus\u2019 psychiatric nurse practitioner diagnoses him with bipolar disorder.<\/span><\/i>\u00a0<\/span><\/p>\n Cases like this are not uncommon with bipolar disorder<\/a>, as initial assessments rarely provide all the information needed. In your role, as a psychiatric nurse practitioner, you must develop strategies for properly assessing and diagnosing these patients because treatments for bipolar disorder are significantly different than treatments for depression or other mood disorders.<\/span>\u00a0<\/span><\/p>\n This week, as you examine bipolar therapies, you explore the assessment and treatment of patients with bipolar disorder. You also consider ethical and legal implications of these therapies.<\/span>\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n \u00a0<\/span>Required Readings<\/span><\/b> (click to expand\/reduce) <\/span><\/a>\u00a0<\/span><\/p>\n \u00a0<\/span>Ostacher, M. J., & Hsin, H. (2016). The use of antiepileptic drugs in psychiatry. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum. (Eds.), <\/span>Massachusetts General Hospital psychopharmacology and neurotherapeutics<\/span><\/i>\u202f(pp. 93\u201398). Elsevier.<\/span>\u00a0<\/span><\/p>\n Perlis, R. H., & Ostacher, M. J. (2016a). Bipolar disorder. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum. (Eds.), <\/span>Massachusetts General Hospital psychopharmacology and neurotherapeutics<\/span><\/i>\u202f(pp. 48\u201360). Elsevier.<\/span>\u00a0<\/span><\/p>\n Perlis, R. H., & Ostacher, M. J. (2016b). Lithium and its role in psychiatry. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum. (Eds.), <\/span>Massachusetts General Hospital psychopharmacology and neurotherapeutics<\/span><\/i>\u202f(pp. 86\u201392). Elsevier.<\/span>\u00a0<\/span><\/p>\n Traeger, L., Brennan, M. M., & Herman, J. B. (2016). Treatment adherence. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum. (Eds.), <\/span>Massachusetts General Hospital psychopharmacology and neurotherapeutics<\/span><\/i>\u202f(pp. 20\u201326). Elsevier.\u202f\u202f<\/span>\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n American Psychiatric Association. (2010b). <\/span>Practice guideline for the treatment of patients with bipolar disorder <\/span><\/i>(2nd ed.)<\/span>. <\/span><\/i>https:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/bipolar.pdf<\/span><\/a>\u00a0<\/span><\/p>\n \ufffc<\/span>\u00a0<\/span><\/p>\n Chen, R., Wang, H., Shi, J., Shen, K., & Hu, P. (2015). Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: Comparison of traditional phenotype and activity score systems. <\/span>European Journal of Clinical Pharmacology, 71<\/span><\/i>(7), 835\u2013841. https:\/\/doi.org\/10.1007\/s00228-015-1855-6<\/span><\/a>\u00a0<\/span><\/p>\n \ufffc<\/span>\u00a0<\/span><\/p>\n Hirschfeld, R. M. A. (n.d.). <\/span>Guideline watch: Practice guideline for the treatment of patients with bipolar disorder<\/span><\/i>\u202f(2nd ed.)<\/span>.<\/span><\/i>\u202f https:\/\/psychiatryonline.org\/pb\/assets\/raw\/sitewide\/practice_guidelines\/guidelines\/bipolar-watch.pdf<\/span><\/a>\u00a0<\/span><\/p>\n \ufffc<\/span>\u00a0<\/span><\/p>\n Vitiello, B. (2013). How effective are the current treatments for children diagnosed with manic\/mixed bipolar disorder? <\/span>CNS Drugs, 27<\/span><\/i>(5), 331\u2013333. https:\/\/doi.org\/10.1007\/s40263-013-0060-3<\/span><\/a>\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n Medication Resources<\/span><\/b> (click to expand\/reduce) <\/span><\/a>\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n U.S. Food & Drug Administration. (n.d.). <\/span>Drugs@FDA: FDA-approved drugs<\/span><\/i>. https:\/\/www.accessdata.fda.gov\/scripts\/cder\/daf\/index.cfm<\/span><\/a>\u00a0<\/span><\/p>\n \u00a0<\/span><\/p>\n Note:\u202f<\/span><\/b>To access the following medications, use the Drugs@FDA resource. Type the name of each medication in the keyword search bar. Select the hyperlink related to the medication name you searched. Review the supplements provided and select the package label resource file associated with the medication you searched. If a label is not available, you may need to conduct a general search outside of this resource provided. Be sure to review the label information for each medication as this information will be helpful for your review in preparation for your Assignments.<\/span>\u00a0<\/span><\/p>\nLearning Objectives<\/span><\/b>\u00a0<\/span><\/h2>\n
Students will:<\/span><\/b>\u00a0<\/span><\/h3>\n
\n
Learning Resources<\/span><\/b>\u00a0<\/span><\/h2>\n
Review the following medications:<\/span><\/b>\u00a0<\/span><\/h2>\n